Continuous Glucose Monitoring and the Effect of Liraglutide in Cardiac Surgery Patients: A Substudy of the Randomized Controlled GLOBE Trial.
Maartina J P Oosterom-EijmaelJeroen HermanidesDaniël H van RaalteImre W K KouwJ Hans DeVriesAbraham H HulstPublished in: Journal of cardiothoracic and vascular anesthesia (2024)
Despite intraoperative sensor interruption, CGM seems an accurate method for semi-invasive, real-time assessment of blood glucose levels. CGM can provide a detailed observation of the pre- and postoperative glycemic trajectory, demonstrating increased time in range following perioperative liraglutide treatment compared with placebo.
Keyphrases
- blood glucose
- cardiac surgery
- phase iii
- patients undergoing
- end stage renal disease
- double blind
- ejection fraction
- glycemic control
- newly diagnosed
- phase ii
- clinical trial
- acute kidney injury
- placebo controlled
- chronic kidney disease
- type diabetes
- peritoneal dialysis
- randomized controlled trial
- high resolution
- adipose tissue
- skeletal muscle
- insulin resistance
- patient reported outcomes
- weight loss